Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Most Shorted Stocks
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Investors
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Most Shorted Stocks
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Center
Investors
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
INKT
Stock Latest News
Ratings
Analyst Maintains Buy on MiNK Therapeutics, Reiterates $35 Price Target on Promising Early Data for agenT-797
6d ago
INKT
Premium
The Fly
MiNK Therapeutics presents early observations from Phase 2 agenT-797 trial
13d ago
INKT
Premium
Company Announcements
MiNK Therapeutics Advances Phase 2 Trial of agenT-797 in Severe Pneumonia: What Investors Should Watch
2M ago
INKT
Premium
Company Announcements
MiNK Therapeutics Stockholders Back Directors, Ratify Auditor
2M ago
8K
INKT
Premium
The Fly
MiNK Therapeutics doses first patient in agenT-797 trial
3M ago
INKT
Premium
The Fly
MiNK Therapeutics reports new data on agenT-797 at ATS 2026
3M ago
INKT
Premium
Company Announcements
Mink Therapeutics’ Earnings Call: High Promise, Tight Runway
3M ago
INKT
Premium
The Fly
MiNK Therapeutics initiates agenT-797 clinical trial
3M ago
INKT
Premium
Ratings
Buy Rating on MiNK Therapeutics Driven by Promising Phase 2 Survival Benefit and Immune Activation in PD-1–Refractory Gastric Cancer
4M ago
INKT
Premium
The Fly
MiNK Therapeutics management to meet virtually with B. Riley
4M ago
INKT
Premium
Ratings
MiNK Therapeutics: Buy Rating on Emerging Pulmonary Franchise and Key agenT-797 ARDS Catalyst
5M ago
INKT
Premium
Company Announcements
MiNK Therapeutics’ Earnings Call Signals High-Risk Upside
5M ago
INKT
Premium
Pre-Earnings
INKT Upcoming Earnings Report: What to Expect?
5M ago
INKT
Premium
Company Announcements
MiNK Therapeutics Explores Strategic Partnerships and Trial Collaborations
5M ago
8K
INKT
Premium
Company Announcements
MiNK Therapeutics Appoints New Principal Financial and Accounting Officers
5M ago
8K
INKT
Premium
Market News
3 Penny Stocks to Watch Now, 3/11/26
5M ago
ATPC
INKT
Premium
Market News
Morning News Wrap-Up 3/10/26: Tuesday’s Biggest Stock Market Stories!
5M ago
GD
AMD
Premium
Ratings
MiNK Therapeutics: Buy Rating Backed by Non-Dilutive PRAME iNKT Partnership and Expanded Oncology Upside
5M ago
INKT
Premium
Market News
Why Is MiNK Therapeutics Stock (INKT) Up Today?
5M ago
INKT
Premium
The Fly
MiNK Therapeutics announces strategic collaboration with C-Further
5M ago
INKT
Premium
The Fly
MiNK Therapeutics announces new invariant natural killer T cells data
7M ago
INKT
Premium
The Fly
MiNK, University of Wisconsin-Madison announce Phase 1 agenT-797 trial
7M ago
INKT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
